Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Advanced Breast Cancer
NCT01023204Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2002
- Primary completion
- Jul 2005
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by Bristol Myers Squibb. Started Oct 2002; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01023204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023204.